Inflammation biomarkers in cancer: mechanistic drivers, diagnostic innovations, and future clinical horizons

Pritam Kayal, Ramit Rahaman, Apala Ghosh, Arun Kumar Singh, Princy Kashyap, Manoj Kumar, Aditya Vikram Jain, Manoj Kumar Mishra

Open source

DOI
10.1016/j.intimp.2026.117421
Published
2026-11
Container
International Immunopharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2026.117421,
  title = {Inflammation biomarkers in cancer: mechanistic drivers, diagnostic innovations, and future clinical horizons},
  author = {Pritam Kayal and Ramit Rahaman and Apala Ghosh and Arun Kumar Singh and Princy Kashyap and Manoj Kumar and Aditya Vikram Jain and Manoj Kumar Mishra},
  year = {2026},
  journal = {International Immunopharmacology},
  doi = {10.1016/j.intimp.2026.117421},
  url = {https://doi.org/10.1016/j.intimp.2026.117421}
}

RIS

TY  - JOUR
TI  - Inflammation biomarkers in cancer: mechanistic drivers, diagnostic innovations, and future clinical horizons
AU  - Pritam Kayal
AU  - Ramit Rahaman
AU  - Apala Ghosh
AU  - Arun Kumar Singh
AU  - Princy Kashyap
AU  - Manoj Kumar
AU  - Aditya Vikram Jain
AU  - Manoj Kumar Mishra
PY  - 2026
JO  - International Immunopharmacology
DO  - 10.1016/j.intimp.2026.117421
UR  - https://doi.org/10.1016/j.intimp.2026.117421
ER  - 

APA

Kayal, P., Rahaman, R., Ghosh, A., Singh, A. K., Kashyap, P., Kumar, M., Jain, A. V., & Mishra, M. K. (2026). Inflammation biomarkers in cancer: mechanistic drivers, diagnostic innovations, and future clinical horizons. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117421

Source records